Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders

NCT05486806 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05486806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05486806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2023
Completion date
November 15, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia, msa - multiple system atrophy, neurodegenerative diseases, sca3, synucleinopathies